Pharma Company Cuts Prices to Help Poor

GlaxoSmithKline, one of the largest pharmaceutical companies in the world, have cut the prices of vaccines given to third world countries after calls from UNICEF, reports pharmatimes.com.

On June 13th GSK and several other pharmaceutical companies made a promise to cut the price of the rotavirus vaccine by up to 95%, meaning a child can be fully immunised for just $5. 125 million doses of the vaccine, Rotarix, have been pledged over the next five years to help reduce the current number of deaths by the virus, which stand at 500,000 per year. Countries such as Uganda are said to have welcomed these reductions, as reported by the Daily Monitor.

Justin Forsyth, chief executive of the Save The Children has welcomed GSK’s decision and called it a “landmark move” which will hopefully drive more companies to provide drugs to third world countries in order to prevent highly treatable diseases killing as many as they do.

Want a job in the pharmaceutical industry? See how we can help here

Posted in: Industry News, News
CK Logo in place of featured image